Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 169 participants.

Also called NCT03940066

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 169 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03940066
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03940066. Randomized; no masking; primary purpose prevention. Start 2019-11-12 (actual); primary completion 2024-04-08 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile
Acronym
Monitor- ACS
Condition
Syncope
Condition
Tachycardia
Condition
Arrhythmias, Cardiac
Condition
Heart Diseases
Intervention (Device)
Biomonitor-2 and Kardia mobile
Intervention (Other)
No Intervention
Lead sponsor
Fundación EPIC (class: other)

Record details

Record id
cardio:ct-nct03940066
Content hash
d5eb8c6c3e514b010112ce97a134d6a7d50d5b96dff1f70b0afaba10c0406bd6